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CBCT dose distributions with the ground truth of a planning 
CT acquired the same day as the CBCT.
Results For pelvic cases, all CTN calibration methods re-
sulted in average dose-volume deviations below 1.5 %. RS-
auto provided larger than average errors for pelvic treatments 
for patients with large amounts of adipose tissue. For H&N 
cases, all CTN calibration methods resulted in average 
dose-volume differences below 1.0 % with CBCTr (0.5 %) 
and RSauto (0.6 %) performing best. For lung cases, WL and 
RSauto methods generated dose distributions most similar to 
the ground truth.
Conclusion The RSauto density override approach is an at-
tractive option for CTN adjustments for a variety of anatom-
ical sites. RSauto methods were validated, resulting in dose 
calculations that were consistent with those calculated on 
diagnostic-quality CT images, for CBCT images acquired 
of the lung, for patients receiving pelvic RT in cases without 
excess adipose tissue, and for H&N cases.
Keywords Cone beam computed tomography · Adaptive 
radiation therapy, ART · Dose calculation · Hounsfield 
units · Density
Vergleich unterschiedlicher CT-Kalibrierungsmethoden 
zur Dosisberechnung auf Basis der 
Kegelstrahlcomputertomographie
Zusammenfassung
Ziel Ziel dieser Arbeit ist der Vergleich und die Validierung 
mehrerer CT-Kalibrierungsmethoden zur Dosisberechnung 
auf der Grundlage von Kegelstrahlcomputertomographie(C
BCT)-Aufnahmen.
Abstract
Purpose The aim of this work was to compare and vali-
date various computed tomography (CT) number calibra-
tion techniques with respect to cone beam CT (CBCT) dose 
calculation accuracy.
Methods CBCT dose calculation accuracy was assessed for 
pelvic, lung, and head and neck (H&N) treatment sites for 
two approaches: (1) physics-based scatter correction meth-
ods (CBCTr); (2) density override approaches including as-
signing water density to the entire CBCT (W), assignment 
of either water or bone density (WB), and assignment of ei-
ther water or lung density (WL). Methods for CBCT density 
assignment within a commercially available treatment plan-
ning system (RSauto), where CBCT voxels are binned into six 
density levels, were assessed and validated. Dose-difference 
maps and dose-volume statistics were used to compare the 
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Methoden Bei 4 Becken-, 3 Lungen- und 4 Kopf-Hals-
Patienten wurde die Genauigkeit der Dosisberechnung auf 
der Basis von CBCT-Aufnahmen für die folgenden Ansätze 
untersucht: einerseits Rekonstruktion der CBCT-Aufnah-
men mithilfe eines Streukorrekturalgorithmus (CBCTr) und 
andererseits 3 verschiedene Methoden zur expliziten Zu-
weisung der Elektronendichten auf Basis des CBCT-Daten-
satzes (W: Zuordnung von Wasserdichte auf dem gesamten 
CBCT, WB: Zuordnung von entweder Wasser- oder Kno-
chendichte, WL: Zuordnung von entweder Wasser- oder 
Lungendichte) sowie der in einem kommerziellen Pla-
nungssystem implementierten Methode der automatischen 
Zuordnung von 6 Dichtestufen auf Basis der CBCT-Houns-
field-Werte (RSauto). Als Grundlage zur Evaluierung der Me-
thoden diente die Dosisverteilung, welche anhand einer am 
gleichen Tag wie die CBCT aufgenommenen Planungs-CT 
berechnet wurde. Die Genauigkeit der einzelnen Ansätze 
wurde anhand von Dosis-Volumen-Statistiken und lokalen 
Dosisunterschieden beurteilt.
Ergebnisse Bei den Datensätzen mit Tumoren im Becken-
bereich ist die mittlere Dosisabweichung für alle Kalibrie-
rungsmethoden unter 1,5 %, wobei RSauto in einer überdurch-
schnittlichen Abweichung für Patienten mit einem höheren 
Anteil von Fettgewebe resultiert. Die mittlere Abweichung 
für Kopf-Hals-Patienten beträgt unter 1,0 %, wobei CBCTr 
(0,5 %) und RSauto (0,6 %) am besten abschneiden. WL und 
RSauto resultieren für die Patienten mit Lungentumoren in 
Dosisverteilungen, welche der Referenzdosisverteilung 
entsprechen.
Schlussfolgerung RSauto zur Kalibrierung von CBCT-Auf-
nahmen zur Dosisberechnung ist eine aussichtsreiche Me-
thode für die untersuchten Indikationen. Es wurde gezeigt, 
dass mithilfe von RSauto die Dosisberechnung auf der Basis 
von CBCT-Aufnahmen von Lungen- und Kopf-Hals-Er-
krankungen sowie für Tumoren im Beckenbereich bei Pa-
tienten ohne ein Übermaß an Fettgewebe in einer akkuraten 
Dosisverteilung resultiert.
Schlüsselwörter Cone-Beam-CT · Adaptive 
Strahlentherapie · Dosisberechnung · Hounsfield-
Einheiten · Dichte
Since its introduction, cone beam CT (CBCT) has been 
mainly utilized for image-guided radiotherapy (IGRT) [1–
4]. CBCT images generated prior to treatment can also be 
used for adaptive radiotherapy (ART) [5, 6] in various ways, 
ranging from using the CBCT to estimate the dosimetric 
effect of patient weight loss, CBCT assessment in order to 
choose a “plan-of-the-day,” to dose recalculation and treat-
ment plan generation on CBCT images [7–11]. Commer-
cially available treatment planning systems (TPSs) are now 
able to implement ART strategies.
CBCT image quality is dependent on acquisition param-
eters and, compared with diagnostic-quality planning CT 
images, exhibit increased artifacts and poorer image con-
trast owing to increased scatter, which itself is dependent 
on the size of the scanned object/patient [12–14]. CBCT 
images (CBCTs) generated using XVI on Elekta treatment 
units are not in true CT numbers (CTNs) and, therefore, in 
their original form, such CBCTs cannot be used directly 
for accurate dose computation [12]. In order to be able to 
perform CBCT-based ART, it is important that dose can be 
calculated accurately (i.e., consistent with that calculated on 
diagnostic CT images) on the CBCT image; various meth-
ods have been suggested for CTN adjustment in order to 
achieve this [12, 15–21].
Strategies for CTN adjustment include calibration of the 
CBCT image voxel values with physical density following 
CBCT acquisitions of phantoms with inserts of differing 
densities [15–19]. Richter et al. [17] proposed a method 
based on average CBCT values for separate treatment sites 
in order to generate population-specific conversion curves 
for brain, head and neck (H&N), thorax, and prostate treat-
ment sites. Apart from taking a large amount of time to 
define, conversion curves are subject to errors caused by 
image artifacts and patient variability, resulting in differ-
ences of 5 % and larger between doses calculated on CBCTs 
compared with CT-based calculation [12, 17]. Patient-spe-
cific conversion curves have also been investigated [20]. 
However, these methods are still prone to dosimetric errors 
resulting from CBCT artifacts.
Poludniowski et al. have shown that differences, between 
the doses on CBCT and CT, of less than 2.5 % can be 
achieved when the CBCT has been reconstructed after scat-
ter correction of the individual projections [20, 22]. The 
implementation of such an approach can be slow and dif-
ficult to introduce into a clinical workflow. Commercially 
available systems that generate CBCTs in CTNs by using 
sophisticated scatter-correction algorithms are starting to 
become commercially available in recent software releases. 
However, the accuracy of dose calculation on such images 
has yet to be validated.
Relatively unsophisticated methods, such as density 
overrides of regions of interest, can be used to populate 
CBCTs with density values that result in acceptable dose 
calculation accuracy [12, 20, 21]. Such strategies can be fast 
to implement and can easily be adapted into clinical work-
flows. These techniques are not as sensitive to the problems, 
such as image artifacts, that the more sophisticated methods 
struggle to cope with.
Unlike other studies presented for density assignment 
methods [12, 21] and other approaches [15–20, 23], we use 
radiotherapy planning CTs (PCTCBCT) acquired on the same 
day as the CBCT as the ground truth for dose calculation. 
Thus, we have selected patients with minimal anatomical 
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are displayed in Table 1. To calculate dose on the CBCT 
images, an external patient contour was defined. First, an 
external contour of the CBCT image was defined using the 
TPS automated algorithm that uses a thresholding technique 
based on the image data. Small holes were then removed 
from the threshold-generated volume and finally contours 
not associated with the largest object were deleted. Next, 
a field-of-view (FOV) region of interest (ROI) was defined 
for the CBCT image set (see Table 1 for FOV parameters). 
Finally, with a priori knowledge of the planning CT scan, 
an automated algorithm (available in the TPS) updated the 
external contour of the CBCT (where necessary) to extend 
beyond the CBCT FOV. A missing tissue ROI (with density 
= 1 g/cm3) is created and is defined as the newly generated 
external ROI exterior to the FOV ROI. Figure 1 (top left) 
displays the FOV, external, and missing tissue ROIs for an 
H&N CBCT image as a red contour, green contour, and gray 
color wash, respectively.
CTN adjustment using CBCT reconstruction
Following Poludniowski [20, 22, 29], CBCT reconstruc-
tions (CBCTr) were made after scatter correction. The soft-
ware developed in-house explicitly simulates and corrects 
for scatter in the projection images using the patients PCTorig 
as a prior [20, 22]. A patient-independent look-up table was 
applied to the reconstructed images in order to convert the 
reconstructed CTNs into physical density [29].
CTN adjustment using density overrides
The “water only” (W) method, where all tissue was assigned 
as water (1 g/cm3), was investigated in all three treatment 
sites. For pelvis and lung cases, “water-and-bone” (WB) and 
“water-and-lung” (WL) techniques were also investigated, 
respectively. For WB, the CBCT voxels were assigned as 
either water or bone. Bone ROIs were generated for each 
CBCT image using a segmentation algorithm based on gray 
value thresholds on the PCTorig data and copying the result-
ing ROIs onto the CBCT image. The bone ROIs were edited 
if necessary, to ensure they were appropriate with reference 
differences between CBCTs and planning CTs, eliminating 
the need for, and uncertainties associated with, deformable 
image registration (DIR) [24–27]. Using the original plan-
ning CT (PCTorig), which may have been captured weeks 
before the CBCT, as the ground truth for dose calculation 
is unsuitable in the context of ART because establishing an 
estimate of the difference in dose between that calculated 
on the PCTorig and CBCT is itself a subject of importance. 
We have investigated three anatomical sites: H&N, pelvis 
(prostate and bladder), and lung.
The aim of this work was to assess the CBCT dose cal-
culation accuracy for density override approaches and to 
compare this with the physics-based scatter correction of 
Poludniowski [20, 22]. We evaluated the accuracy of the 
RayStation TPS (V3.99, RaySearch Laboratories, Stock-
holm, Sweden) density override approach and compared 
it with more simple density override methods investigated 
in the literature [12]. We aimed to establish, for different 
anatomical locations, the methods that were best in terms 
of CBCT dose calculation accuracy. The methods for CTN 
adjustment investigated in this work are transferable to dose 
calculation on magnetic resonance (MR) images and could, 
therefore, be of interest to MR-based ART [28].
Patients and methods
We selected patients who had a CBCT and diagnostic CT 
(both with the same immobilization and/or support devices) 
on the same day. The study consisted of four H&N cases, 
four pelvis cases (two prostate and two bladder treatment 
sites), and three lung cases (two left upper lobe GTVs, one 
right upper lobe GTV). The RayStation TPS was used for 
dose calculations, using a collapsed cone algorithm. The 
median time difference between the CBCT and PCTCBCT 
was 59 min (range: 17–215 min).
CBCT dose calculation
The CBCTs were acquired with Elekta XVI-V4.5 (XVI 
Elekta, Stockholm, Sweden); the scanning parameters 
Table 1 CBCT scanning parameters for the three anatomical sites investigated in this studya




Chest S20 120 25 40 26 26 F0 (none) 9.00
Head and neck 
S20
100 10 10 26 26 F0 (none) 0.45
Pelvis M10 120 100 40 40 13 F1 (bowtie) 27.00
CTDI computed tomography dose index.
aThe H&N and lung patients were scanned with a field of view (FOV) of 26 cm allowing a partial gantry rotation for acquisition, but limiting the 
full patient contour (i.e., missing the shoulders on the H&N patients and only seeing the treated sides of the lung patients), whereas acquisitions 
for the pelvis patients were made with the 40-cm FOV.
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able in the TPS where six different set densities (air, lung, 
adipose tissue, connective tissue, cartilage/bone, and higher 
density for prosthesis) are assigned to the CBCT image. 
This is achieved by binning the CBCT image histogram into 
six density levels. The CBCT image thresholds are indi-
vidual to each patient whereas the assigned density values 
are fixed (Fig. 1). An automatic algorithm (RSauto) extracts 
the various density thresholds by approximating the CBCT 
image histogram with two normal distributions which were 
then interrogated to determine the threshold values. The 
physical densities applied by the TPS to the various tissue 
types were: air = 0.00121 g/cm3, lung = 0.26 g/cm3, adipose 
= 0.95 g/cm3, connective tissue = 1.05 g/cm3, cartilage/bone 
= 1.6 g/cm3, and other (such as prosthetic hip) = 3 g/cm3. 
The consideration of the other override approaches (W, WL, 
WB) provides a useful benchmark and understanding for 
the more complex RSauto methodology. Table 2 outlines the 
CTN adjustment techniques investigated in this study.
Limited FOV for lung CBCTs
At our institution, the FOV for CBCT acquisitions for lung 
patients does not encompass the entire patient contour 
(Table 1, Fig. 1). When performing CTN adjustment using 
CBCTr or RSauto, it may, therefore, be necessary to perform 
an additional density override to the contralateral lung. As 
well as applying a density override of 1 g/cm3 to the missing 
tissue ROI (region shaded turquoise in Fig. 1), an additional 
density override of 0.2 g/cm3 was applied to the left lung 
outside of the FOV (shaded orange in Fig. 1). If CBCT scans 
to the CBCT image. The PCTorig bone ROIs were addition-
ally used to establish an appropriate density to assign to the 
CBCT bone ROI. The average CTN of bone ROIs on PCTorig 
was 1,400, which was similar to previously reported data 
[30] and equivalent to 1.35 g/cm3. This density was used 
for all cases included in this study. In the WL technique, the 
patient was assumed to be made up of either water or lung 
tissue (0.2 g/cm3), where the density of lung was calculated 
using similar methods as those used to determine the pelvic 
bone density.
More sophisticated density override techniques were 
investigated using the CBCT density-assignment tools avail-
Table 2 The different CTN adjustment methods investigated in this 
study
Method name Method description Sites used in study
CBCTr CBCT reconstruction 
after scatter correction 
Poludniowski
Pelvis, H&N, lung
W All tissue was assumed to 
be water (1 g/cm3)
Pelvis, H&N, lung
WB CBCT voxels assigned as 
either water or bone
Pelvis
WL CBCT voxels assigned as 
either water or lung
Lung
RSauto CBCT voxels auto-
matically binned into six 
density levels
Pelvis, H&N, lung
CBCTr physics-based scatter correction methods, W assignment of 
water density to the entire CBCT, WB assignment of either water or 
bone density, WL assignment of either water or lung density, RSauto 
RayStation TPS, H&N head and neck.
Fig. 1 The RayStation treatment 
planning system (TPS) cone beam 
computed tomography (CBCT) 
CT number (CTN) adjustment 
method. Top row from left: 
Sagittal slice of a CBCT image 
of an H&N cancer patient viewed 
within the TPS; the CBCT after 
density assignment by the TPS 
(regions assigned as bone are 
shown as yellow, for example); 
CTN-density table generated for 
the CBCT image. Bottom row, 
left: Typical CBCT acquisition 
of a patient with a tumor in their 
right lung and (right) the same 
CBCT image but with the field 
of view (red contour), external 
(green contour), and left lung 
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able image registrations (and their associated uncertainty)
between the original planning CT and CBCT.
Pelvis cases
RSauto tended to underestimate the proportion of lower-den-
sity tissue present in larger patients (Fig. 4), corresponding 
to an underestimation of the dose. This underestimation has 
been observed in a larger cohort of pelvic cases that were 
not used in this dose validation study as they did not have 
a CBCT and CT acquired on the same day. However, for 
patients with anterior-posterior distance (DAP) < 25 cm, 
RSauto resulted in the most accurate dose distributions of all 
CTN adjustment methods with an average of 0.7 % abso-
lute difference in dose when compared with the ground 
truth. Furthermore, for patients with DAP < 25 cm, the WB 
method worked well with the assignment of water (1 g/cm3) 
to all non-bone tissue, being adequate in such cases as these 
patients commonly have similar amounts of lower-density 
(0.95 g/cm3) and connective (1.05 g/cm3) tissue. However, 
for patients with higher proportions of adipose tissue, the 
WB method did not perform as well. The W method per-
formed better than WB for patients with DAP > 25 cm, with 
the additional adipose tissue being balanced out by the 
higher-density bone. The CBCTr method was unable to 
accurately reconstruct higher-density material for the larger 
patient, resulting in a similar effect to that observed with 
the W method for patients with DAP < 25 cm. For this treat-
ment site, the RSauto method produced the best results when 
compared with the ground truth, with an average absolute 
difference of 0.7 % (range: 0.1–2.5 %) when only consider-
of the lung were to be routinely used for dose calculation, 
we would recommend using either a medium or large FOV 
to ensure the entire patient contour at the superior/inferior 
extent of the tumor was encompassed. This contralateral 
lung density issue has only a small effect on treatments 
where all beams enter ipsilaterally. However, for treatments 
where one (or more) beams entered contralaterally, the lung 
ROI from the planning CT scan was copied to the CBCT 
image and a density override was applied (Fig. 1).
Data analysis
Dose statistics and dose-difference maps were generated 
using the TPS. Dose–volume histogram (DVH) analysis 
was performed on ROIs that were propagated to the CBCT 
from the PCTCBCT scan.
Results
Differences in dose-volume statistics between that calcu-
lated on the CBCT and the ground truth, for all three treat-
ment sites, are shown in Table 3 and Fig. 2.
Internal anatomy variability of a prostate case is illus-
trated in Fig. 3, demonstrating that the use of PCTCBCT as 
the ground truth is, in some instances, essential for mean-
ingful DVH dosimetric comparison for CBCT dose calcula-
tion accuracy. Previous studies [12, 15–21, 23] of CBCT 
dose calculation accuracy have either used rigid (which may 
have been acquired weeks prior to the CBCT and there-
fore exhibit substantial anatomical differences) or deform-
Fig. 2 Dose difference maps 
for between doses calculated on 
CBCT images and the ground 
truth (PCTCBCT). From top row 
to bottom: (1) a pelvic case with 
anterior-posterior distance (DAP) 
= 23 cm; (2) a pelvic case with 
DAP = 32 cm; (3) an H&N case; 
and (4) a lung case. All dose dif-
ference maps are presented as a 
percentage of the prescribed dose
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H&N cases
All three methods investigated for CTN adjustment for 
H&N cases resulted in acceptable [20] average absolute 
dose deviations of ≤ 1.0 % when compared with the ground 
truth, with CBCTr (0.5 %) and RSauto (0.6 %) performing 
best. For CBCT images acquired of the H&N, on the basis 
of the results presented in Table 3, its integration within a 
ing patients with DAP < 25 cm. For CBCT images acquired 
around the pelvis of patients with DAP < 25 cm, we therefore 
recommend using the RSauto method for CTN adjustment. 
However, the WB and W methods worked with sufficient 
accuracy [20] for patients with DAP < 25 cm and > 25 cm, 
respectively.

















CTV Dmedian 0.8 (0.5–1.2) 0.3 (− 1.3–1.7) − 1.0 (− 1.6–− 0.1) − 1.3 (− 2.6–− 0.1)
D95 % 0.8 (0.0–2.0) 0.0 (− 2.4–1.4) − 1.5 (− 2.7–− 0.4) − 1.5 (− 3.7–− 0.2)
D98 % 0.8 (0.0–2.0) − 0.1 (− 2.6–1.4) − 1.5 (− 2.8–− 0.4) − 1.7 (− 3.9–− 0.4)
D2 % 1.2 (0.7–1.5) 0.7 (− 0.2–1.9) − 0.7 (− 1.4–− 0.2) − 0.8 (− 1.2–0.1)
Femoral heads D50 % 2.4 (1.6–3.1) 0.9 (− 1.2–3.9) − 1.1 (− 1.8–− 0.5) − 0.7 (− 1.5–− 0.1)
Rectum D50 % 1.4 (− 0.2–4.2) 0.2 (− 1.1–1.1) − 1.0 (− 1.8–0.5) 0.7 (− 1.3–0.6)
Bladder Dmean 0.4 (0.0–0.8) 0.1 (− 0.3–0.4) − 1.0 (− 1.2–− 0.8) − 1.5 (− 1.6–− 1.4)
Averagea 1.4 (− 0.3–4.2) 0.0 (− 2.6–3.9) − 1.0 (− 2.8–0.5) − 1.1 (− 3.9–2.0)
Absolute averagea 1.4 (0.0–4.2) 0.7 (0.0–3.9) 1.0 (0.1–2.8) 1.2 (0.0–3.9)
Head and neck treatments
CTV Dmedian 0.3 (− 0.1–1.0) 0.4 (0.0–1.3) − 0.1 (− 0.6–0.1)
D95 % 0.5 (0.1–0.9) 1.9 (0.2–4.7) 0.2 (− 0.3–1.0)
D98 % 0.4 (0.0–0.9) 0.4 (0.0–0.8) − 0.1 (− 0.3–0.0)
D2 % 0.3 (− 0.2–1.0) 0.8 (0.1–1.4) − 0.1 (− 0.4–0.2)
Spinal cord D2 % 0.7 (0.0–1.7) 1.4 (1.0–2.5) 0.5 (− 0.1–1.0)
Brain stem D2 % 0.5 (− 0.6–1.4) 0.5 (− 1.7–1.6) − 0.5 (− 2.5–0.6)
Parotids Dmean 0.5 (0.0–1.1) 0.4 (− 0.5–1.4) − 0.3 (1.5 − 0.4)
Averageb 0.4 (− 0.6–1.7) 0.8 (− 1.7–4.7) − 0.1 (− 2.5–1.0)
Absolute averageb 0.5 (0.0–1.7) 1.0 (0.0–4.7) 0.6 (0.1–2.5)
Lung treatments
CTV Dmedian 2.4 (1.9–2.9) − 6.8 (− 7.7–− 6.1) 0.4 
(− 0.6–0.9)
− 1.3 (− 2.1–− 0.8)
D95 % 0.0 (− 1.7–1.7) − 7.0 (− 7.4–− 6.5) 0.5 
(− 2.0–1.8)
− 1.1 (− 1.7–− 0.7)
D98 % − 1.3 (− 4.8–2.2) − 6.9 (− 7.1–− 6.6) 0.3 
(− 2.7–2.2)
− 1.0 (− 1.5–− 0.7)
D2 % 3.0 (1.9–4.1) − 6.2 (− 6.6–− 5.9) 0.8 
(− 0.1–1.4)
− 0.9 (− 2.3–0.5)
Heart Dmean − 0.2 (− 3.4–2.9) − 3.4 (− 8.7–1.7) − 0.9 
(− 3.3–1.2)
− 2.2 (− 4.0–− 0.8)
Lungs Dmean 2.9 (− 1.0–8.0) − 7.8 (− 12.7–4.6) 0.4 
(− 1.6–1.6)
− 1.8 (− 3.9–− 0.3)
Spinal cord D2 % 3.7 (3.0–4.4) − 2.4 (− 5.7–1.4) 1.1 (0.0–1.7) − 0.8 (− 1.9–0.5)
Averagec 1.5 (− 4.8–8.0) − 5.9 (− 12.7–1.7) 0.2 
(− 3.3–1.8)
− 1.4 (− 4.0–0.5)
Absolute averagec 2.8 (1.0–8.0) 6.1 (1.4–12.7) 1.3 (0.0–3.3) 1.4 (0.3–4.0)
W water, WB water or bone, WL water or lung, CTV clinical target volume.
aAverage values are the mean of the dose difference statistics for all CTVs (D98 %, D95 %, mean, D50 %, D 2 %), D50 % for femoral heads, Dmean 
for bladder, D50 % and D2 % for rectum.
bThe average values are the mean of the dose difference statistics for all CTVs (D95 %, mean, D50 %, D 2 %), D50 % for parotids, D2 % for brain stem 
and spinal cord.
cThe average values are the mean of the dose difference statistics for the CTV (D98 %, D95 %, mean, D50 %, D 2 %), mean dose to heart and healthy 
lung, D2 % for spinal cord.
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employed for the contralateral lung ROIs (Fig. 1), this dose 
disagreement may be improved by generating additional 
bone ROIs for the shoulders to enable more accurate dose 
calculation on the CBCT data set.
Lung cases
Assuming that density overrides external to the FOV ROI 
were applied as per Fig. 1, the WL and RSauto methods gen-
erated dose distributions most similar to PCTCBCT calcula-
tions, with average absolute dose differences of 1.3 and 
1.4 %, respectively (Table 3). When the RSauto or CBCTr 
methods were applied to VMAT treatments without apply-
ing additional contralateral lung density overrides, the aver-
age absolute dose difference increased to over 3.0 %. The 
W method performed poorly for lung cases as, unlike the 
other methods investigated for this site, it did not account 
for the lower-density lung tissue present. On the basis of 
the results presented in Table 3, for CBCT images acquired 
of the lung, we recommend using either the RSauto or WL 
method for CTN adjustment. This study did not investigate 
the dependence of CBCT-based dose calculations on lung 
intra-fraction motion.
TPS, and its ease and speed of implementation, we recom-
mend using the RSauto method for CTN adjustment. Larger 
dose differences were observed in the inferior part of the 
target at the level of the shoulders. Similar to the methods 
Fig. 4 Sagittal (top row) and coronal slices (bottom row) of a pelvic 
case with a high proportion of adipose tissue. From left to right: the 
PCTCBCT with tissue density < 0.95 g/cm
3 colored purple, and CBCT 
with RSauto CTN adjustment. In the CBCT images purple, turquoise, 
and yellow represent adipose (0.95 g/cm3), connective tissue (1.05 g/
cm3), and bone (1.6 g/cm3), respectively. PCT planning computed to-
mography, CBCT cone beam CT, CTN CT number
 
Fig. 3 Left: Sagittal images of a prostate RT treatment plan with dose 
calculated on (top) the PCTorig; (middle) PCTCBCT; and (bottom) the 
CBCT. The rectum is shown as an orange contour and the dose is 
shown in color wash relative to the prescribed dose. Right: dose–vol-
ume histogram of the rectum for the dose calculated on the PCTorig 
scan (orange line); the PCTCBCT (blue line); and the CBCT (red dashed 
line). The RSauto method was used for CTN adjustment of the CBCT 
image. The rectum OAR was similar in size and shape on the CBCT 
and the PCTCBCT but was very different to that seen on the PCTorig scan. 
PCT planning computed tomography, CBCT cone beam CT, CTN CT 
number, OAR organ at risk
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Conclusion
We investigated various methods, including RSauto that has 
not been assessed before, for CTN adjustment for CBCT 
dose calculations. RSauto methods were validated, resulting 
in CBCT dose calculations for lung patients, for patients 
treated in the pelvis with DAP < 25 cm, and for H&N cases, 
which were similar to those calculated on diagnostic CT 
images. Its implementation into a commercially available 
TPS makes the RSauto approach the fastest and easiest-to-use 
of all methods investigated in this study and it can easily be 
performed as part of a typical clinical workflow. The differ-
ences reported in this study between the doses calculated 
on the CBCT compared with the ground truth, when using 
density overrides, were similar to other reported results [12] 
and better than those that use CBCT-density look-up table 
methods [12]. However, in this study we used a planning CT 
acquired on the same day as the CBCT as the ground truth in 
order to minimize the uncertainties often present in studies 
of this kind. Although the RayStation TPS was used for this 
work, the methods described could be replicated in other 
treatment planning systems. Furthermore, the density over-
ride methods for CTN adjustment that were investigated in 
this work are applicable and transferable to dose calculation 
on segmented MR images.
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Discussion
For the sites investigated in this study, the differences 
between the doses calculated on the CBCT compared with 
the diagnostic CT, when using RSauto, were similar or bet-
ter than other reported results. Fotina et al. demonstrated 
that density override techniques applied to CBCT scans of 
the prostate resulted in dosimetric differences below 2 %, 
whereas the use of conversion curves to calculate dose on 
CBCT images has been shown to result in differences of 
up to 5 % [12]. However, Richter et al. demonstrated that 
conversion curves specific to anatomical sites can result 
in comparable dose calculation accuracy with differences 
below 2 % [17].
Owing to weight loss during radiotherapy for H&N can-
cer [7, 24, 31, 32], for the H&N cases it was necessary to 
use the PCTCBCT as the input to the algorithm within the TPS 
used to define the CBCT body contour. When the PCTorig 
was used, the large differences in the body contour between 
the PCTCBCT and CBCT meant dose differences between 
that calculated on the CBCT and the ground truth could not 
be assessed with confidence. The use of the PCTCBCT data 
as a priori knowledge for this validation study reduced the 
uncertainty of the shape of the CBCT body contour, result-
ing in more accurate estimations of CBCT dose. If CBCT 
scans of the H&N were to be routinely used for dose calcu-
lation, we would recommend using either a medium or large 
FOV to ensure the entire patient contour at the superior/
inferior extent of the tumor was imaged in order to gener-
ate the entire patient contour on the CBCT image. Cupping 
artifacts can have a large effect on CBCT dose calculations, 
and the degree to which they affect the dose depends on 
the CTN adjustment method used. CBCT-density look-up 
table techniques are the most sensitive in this context. How-
ever, CBCT dose distributions generated using density over-
ride methods, such as those discussed in this study, are also 
affected by image quality with increasing sensitivity with 
increasing number of density bins. However, the results 
indicate that binning the CBCT voxels into six densities is 
an appropriate methodology that results in dose distribu-
tions that are sufficiently accurate. As well as automatically 
defining the density threshold levels, the TPS allows them 
to be manually defined by the user. Especially important for 
larger-sized patients, this approach could be used to ensure 
an appropriate proportion is assigned as lower-density adi-
pose tissue. However, tissue assignment as a manual pro-
cess is subject to error, which was not investigated in this 
study but will be explored in future work. Although this 
study involved a small number of cases in each of the three 
treatment sites, we believe that we have identified patients 
with minimal anatomic differences between the CBCT and 
PCTCBCT, enabling the accuracy of CBCT dose calculation to 
be assessed and for the RSauto method to be validated.
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